Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

High IGHV Intraclonal Diversification Identifies CLL with Good Prognosis, Features of Anergy and Specific T-Cell Profiles

Blood (2024) 144 (Supplement 1): 75.

https://doi.org/10.1182/blood-2024-203003

Published: 2024

Journal Articles

CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World Experience

Blood (2023) 142 (Supplement 1): 3281.

https://doi.org/10.1182/blood-2023-174897

Published: 2023

Journal Articles

An Unsupervised Machine Learning Method Stratifies Chronic Lymphocytic Leukemia Patients into Novel Categories with Different Risk of Early Treatment

Blood (2023) 142 (Supplement 1): 1892.

https://doi.org/10.1182/blood-2023-177884

Published: 2023

Journal Articles

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?

Blood (2018) 132 (Supplement 1): 5531.

https://doi.org/10.1182/blood-2018-99-111450

Published: 2018

Journal Articles

Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia

Blood (2018) 132 (Supplement 1): 945.

https://doi.org/10.1182/blood-2018-99-111452

Published: 2018

Journal Articles

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

Elena Vendramini, PhD, Riccardo Bomben, PhD, Federico Pozzo, PhD, Dania Benedetti, PhD, Maria Francesca Rossi, PhD, Michele Dal Bo, PhD, Gabriele Pozzato, MD, Francesco Zaja, MD, Annalisa Chiarenza, MD PhD, Francesco Di Raimondo, MD, Giovanni Del Poeta, MD, Valter Gattei, MD, Antonella Zucchetto

Blood (2018) 132 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2018-99-111864

Published: 2018

Journal Articles

Apoptosis Resistance and NOTCH1 Mutations Impair Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Ibrutinib

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, Massimiliano Postorino, Riccardo Bomben, Emilia Iannella, Francesco Buccisano, MD, Maria Francesca Rossi, Adriano Venditti, MD, Enrico Santinelli, Paolo de Fabritiis, Maria Cantonetti, Sergio Amadori, MD, Valter Gattei, MD, William Arcese, MD

Blood (2017) 130 (Supplement 1): 261.

https://doi.org/10.1182/blood.V130.Suppl_1.261.261

Published: 2017

Journal Articles

Comprehensive Characterization of NOTCH1 Mutational Status in Chronic Lymphocytic Leukemia: Clinical Relevance of Subclonal Mutations and Mutation Types

Tiziana D'Agaro, Tamara Bittolo, Vanessa Bravin, Antonella Zucchetto, Michele Dal Bo, Francesca Rossi, Federico Pozzo, Annalisa Chiarenza, Giovanni D'Arena, Gabriele Pozzato, Francesco Zaja, Davide Rossi, MD PhD, Francesco Di Raimondo, MD, Gianluca Gaidano, MD PhD, Giovanni Del Poeta, MD, Pietro Bulian, Valter Gattei, Riccardo Bomben

Blood (2016) 128 (22): 3195.

https://doi.org/10.1182/blood.V128.22.3195.3195

Published: 2016

Journal Articles

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Massimiliano Postorino, Michele Dal Bo, Maria Francesca Rossi, Francesco Buccisano, Luca Maurillo, MD, Davide Rossi, Livio Pupo, Benedetta Mariotti, Adriano Venditti, MD, Paolo de Fabritiis, MD, Maria Cantonetti, Gianluca Gaidano, Francesco Lo Coco, MD, Valter Gattei, Sergio Amadori, MD

Blood (2016) 128 (22): 3204.

https://doi.org/10.1182/blood.V128.22.3204.3204

Published: 2016

Journal Articles

Lack of Prognostic Significance of the Conventional and Novel Prognostic Markers in Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Blood (2016) 128 (22): 4354.

https://doi.org/10.1182/blood.V128.22.4354.4354

Published: 2016

Journal Articles

The B-Cell Receptor Signaling Inhibitor Molecules CD305 and CD307b Are Markers of Favorable Prognosis in Chronic Lymphocytic Leukemia with Both Mutated and Unmutated IGHV Gene Status

Dania Benedetti, Claudia Perini, Erika Tissino, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesca Rossi, Massimo Degan, Alessandro Poggi, Mahdi Shabani, Fazel Shokri, Francesco Zaja, MD, Gabriele Pozzato, Annalisa Chiarenza, Francesco Di Raimondo, MD, Giovanni Del Poeta, MD, Valter Gattei, Antonella Zucchetto

Blood (2016) 128 (22): 4358.

https://doi.org/10.1182/blood.V128.22.4358.4358

Published: 2016

Journal Articles

Mutations at 3' Untranslated Region (3'UTR) of NOTCH1 Are Associated with Low CD20 Expression Levels in Chronic Lymphocytic Leukemia

Blood (2016) 128 (22): 306.

https://doi.org/10.1182/blood.V128.22.306.306

Published: 2016

Journal Articles

CD49d Prevails over the Novel Recurrent Mutations As Independent Prognosticator of Overall Survival in Chronic Lymphocytic Leukemia

Blood (2015) 126 (23): 1706.

https://doi.org/10.1182/blood.V126.23.1706.1706

Published: 2015

Journal Articles

Retention of inside-out VLA-4 Integrin Activation upon B-Cell Receptor Triggering in in-Vitro and in-Vivo Ibrutinib Treated Chronic Lymphocytic Leukemia Cells: Clinical Implication

Erika Tissino, Chiara Caldana, Dania Benedetti, Francesca Rossi, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesco Zaja, MD, Annalisa Chiarenza, Tanja Nicole Hartmann, Alexandre Chigaev, Giovanni Del Poeta, Valter Gattei, Antonella Zucchetto

Blood (2015) 126 (23): 1708.

https://doi.org/10.1182/blood.V126.23.1708.1708

Published: 2015

Journal Articles

The Concomitant High Expression of the B-Cell Receptor Signaling Inhibitor Molecules CD150, CD305, and CD307b Predicts Longer Overall Survival in the Context of Low-Risk Chronic Lymphocytic Leukemia

Antonella Zucchetto, Dania Benedetti, Chiara Caldana, Erika Tissino, Michele Dal Bo, Pietro Bulian, Riccardo Bomben, Francesca Rossi, Francesco Zaja, MD, Gabriele Pozzato, Annalisa Chiarenza, Francesco Di Raimondo, MDPhD, Giovanni Del Poeta, Valter Gattei

Blood (2015) 126 (23): 1720.

https://doi.org/10.1182/blood.V126.23.1720.1720

Published: 2015

Journal Articles

Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance

Rosella Famà, Riccardo Bomben, Silvia Rasi, Michele Dal Bo, Carmela Ciardullo, Sara Monti, Francesca Rossi, Tiziana D’Agaro, Antonella Zucchetto, Valter Gattei, Gianluca Gaidano, Davide Rossi

Blood (2014) 124 (25): 3831–3833.

https://doi.org/10.1182/blood-2014-08-592725

Published: 2014

Includes: Supplemental data

Journal Articles

Front-Line Treatment of Low-Grade Non-Follicular Non-Hodgkin Lymphoma (Final Report of Gisl LL02 Trial).

Maria Goldaniga, Francesco Merli, Caterina Stelitano, Vincenzo Callea, Fiorella Ilariucci, Mario Russo, Patrizio Mazza, Stefano Luminari, Francesca Rossi, Maura Brugiatelli, Dimitri Luisi, Barbara Olivero, Giorgio Lambertenghi Deliliers, Massimo Federico, Luca Baldini

Blood (2007) 110 (11): 2332.

https://doi.org/10.1182/blood.V110.11.2332.2332

Published: 2007

Journal Articles

Von Hippel-Lindau–dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster

Silverio Perrotta, Bruno Nobili, Marcella Ferraro, Carmela Migliaccio, Adriana Borriello, Valeria Cucciolla, Vincenzo Martinelli, Francesca Rossi, Francesca Punzo, Paola Cirillo, Giuseppe Parisi, Vincenzo Zappia, Bruno Rotoli, Fulvio Della Ragione

Blood (2006) 107 (2): 514–519.

https://doi.org/10.1182/blood-2005-06-2422

Published: 2006

Journal Articles

The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function

Silverio Perrotta, Adriana Borriello, Andrea Scaloni, Lucia De Franceschi, Anna Maria Brunati, Francesco Turrini, Vincenzo Nigro, Emanuele Miraglia del Giudice, Bruno Nobili, Maria Luisa Conte, Francesca Rossi, Achille Iolascon, Arianna Donella-Deana, Vincenzo Zappia, Vincenzo Poggi, William Anong, Philip Low, Narla Mohandas, Fulvio Della Ragione

Blood (2005) 106 (13): 4359–4366.

https://doi.org/10.1182/blood-2005-07-2806

Published: 2005

Journal Articles

New Insights into the Function of N-Terminal 11 Amino Acids of Band 3 from Structural and Functional Study of a Naturally Occuring Band 3 Variant.

Silverio Perrotta, Borriello Adriana, Lucia De Franceschi, Bruno Nobili, Achille Iolascon, Anna Maria Brunati, Francesca Rossi, Francesco Turrini, Fulvio Della Ragione, Philip Low, Narla Mohandas

Blood (2004) 104 (11): 577.

https://doi.org/10.1182/blood.V104.11.577.577

Published: 2004

NARROW

High IGHV Intraclonal Diversification Identifies CLL with Good Prognosis, Features of Anergy and Specific T-Cell Profiles

CD49d Expression Is Included in a Revised 4-Factor Model Predicting Outcome in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Multi-Center Real-World Experience

An Unsupervised Machine Learning Method Stratifies Chronic Lymphocytic Leukemia Patients into Novel Categories with Different Risk of Early Treatment

The VLA-4 Integrin Is Constitutively Activated in a Subset of CD49d-Expressing CLL: A Relationship with the Autonomous BCR-Mediated Signaling?

Clinical Impact of Clonal and Subclonal TP53 Mutations in Chronic Lymphocytic Leukemia

KRAS , NRAS and BRAF Mutations Are Highly Enriched in TRI12 Chronic Lymphocytic Leukemia and Are Associated to Shorter Time to First Treatment

Apoptosis Resistance and NOTCH1 Mutations Impair Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Ibrutinib

Comprehensive Characterization of NOTCH1 Mutational Status in Chronic Lymphocytic Leukemia: Clinical Relevance of Subclonal Mutations and Mutation Types

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Lack of Prognostic Significance of the Conventional and Novel Prognostic Markers in Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

The B-Cell Receptor Signaling Inhibitor Molecules CD305 and CD307b Are Markers of Favorable Prognosis in Chronic Lymphocytic Leukemia with Both Mutated and Unmutated IGHV Gene Status

Mutations at 3' Untranslated Region (3'UTR) of NOTCH1 Are Associated with Low CD20 Expression Levels in Chronic Lymphocytic Leukemia

CD49d Prevails over the Novel Recurrent Mutations As Independent Prognosticator of Overall Survival in Chronic Lymphocytic Leukemia

Retention of inside-out VLA-4 Integrin Activation upon B-Cell Receptor Triggering in in-Vitro and in-Vivo Ibrutinib Treated Chronic Lymphocytic Leukemia Cells: Clinical Implication

The Concomitant High Expression of the B-Cell Receptor Signaling Inhibitor Molecules CD150, CD305, and CD307b Predicts Longer Overall Survival in the Context of Low-Risk Chronic Lymphocytic Leukemia

Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance

Front-Line Treatment of Low-Grade Non-Follicular Non-Hodgkin Lymphoma (Final Report of Gisl LL02 Trial).

Von Hippel-Lindau–dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster

The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function

New Insights into the Function of N-Terminal 11 Amino Acids of Band 3 from Structural and Functional Study of a Naturally Occuring Band 3 Variant.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only